Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jparsons
    Member
    • Feb 2012
    • 62

    #1

    State of the Art - RNAseq

    This question really boils down to the following: If you were to do an RNA-seq experiment today (let's limit the sequencing to illumina) what protocols/kits would you use?

    *For single-cell / low-volume (let's assume a few hundred cells)
    *For a typical bulk treatment/control experiment

    As a bit of background, I've got a few ideas right now that involve

    *Demonstrating biases in polyA-selection
    *Quantitatively assessing the single-cell seq process

    I am wondering whether the first will be of negligible impact because tagmentation makes polyA selection less common, and that left me wondering about the single-cells. Are there clear frontrunners in these areas of prep?
    Last edited by jparsons; 10-03-2014, 03:08 PM.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    This question really boils down to the following: If you were to do an RNA-seq experiment today (let's limit the sequencing to illumina) what protocols/kits would you use?

    *For single-cell / low-volume (let's assume a few hundred cells)
    *For a typical bulk treatment/control experiment
    I would use Clontech SMARTer kits for single-cell and Illumina's kits for bulk RNA. There are lots of published methods and also comparative studies of various kits and methods. By the time that comparative studies are published new methods are out so one may not be able to make a performance based decision.
    Last edited by nucacidhunter; 10-05-2014, 06:23 PM.

    Comment

    • thomasblomquist
      Member
      • Jul 2012
      • 68

      #3
      Originally posted by nucacidhunter View Post
      I would use Clontech SMARTer kits for single-cell and Illumina's kits for bulk RNA. There are lots of published methods and also comparative studies of various kits and methods. By the time that comparative studies are published new methods are out so one may not be able to make a performance based decision.
      I recommend you peruse the findings from the FDA sponsored Sequencing Quality Control Consortium project http://www.nature.com/nbt/journal/v3.../nbt.3025.html .

      One of the principle findings is that no platform, or kit for library prep, provides TRUE accuracy. There is always bias. There is a large degree of agreement between platforms for detecting FOLD-change. But even this can be different between approaches as FRAGMENTATION is not always uniform from day-to-day tech-to-tech.

      The key is to stick to a protocol, and it is probably best to batch cases/controls and process in parallel for RNA-seq experiments.

      Other key pieces of information: 1) Favor biological replicates over technical replicates. And 2) ultra-deep sequencing only gets you so much information when you are stochastically sampling biological noise. Be careful how deep you sequence.

      Good luck,

      This is a big beast to harness.

      -Tom Blomquist

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      53 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      40 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Working...